Amines and Plasticizers Q1FY27: Holding profitability through a disrupted quarter
Ask Iris
Frequently Asked Questions
Q1FY27 revenue from operations was 150.53 crore, EBITDA was 15.14 crore, and net profit was 9.47 crore as per the consolidated quarterly P&L table.
Q1FY27 revenue contribution was Alkanolamines and Alkyl Alkanolamines 43.21%, Gas Treating Chemicals and Specialty Solvents 35.60%, EO/PO-Based Specialty Products 10.70%, Morpholine and Derivatives 9.31%, and Others 1.18%.
FY26 revenue contribution was Gas Treating Chemicals and Specialty Solvents 44.19%, Alkanolamines and Alkyl Alkanolamines 33.09%, Morpholine and Derivatives 10.25%, EO/PO-Based Specialty Products 10.98%, and Others 1.49%.
Management stated geopolitical conditions increased raw material and finished goods prices and the quarter included inventory gains due to high opening inventory. Plants operated at partial capacity due to limited and costly fuel and gas availability.
The presentation states installed capacity for speciality amines production is 32,760 MTPA at Unit 01 Turbhe.
The company states it serves customers across 85 plus countries.
FY26 R&D spend was 2.11 crore; the R&D team size is 6 members with 2 doctorates and 4 chemists; DSIR recognition is stated as yes; and 43 new products were commercialised over the last 5 years.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
